The regulator said it had found several violations with regard to current good manufacturing practices (CGMP) at three of its plants. Dr Reddy's Laboratories The US Food and Drug Administration (US FDA), which had issued a warning letter to Dr ... DNA India, 10 hours ago
US Drug Regulator Warns Dr Reddy's of Import Ban - MyInforms, 1 day ago
Drugmaker's shares plunge as FDA issues warning on India sites - Nikkei Asian Review, 4 hours ago
said it will respond with a plan to address the observation within the stipulated time FDA inspected three DRL manufacturing sites in Telangana and Andhra Pradesh between November 2014 and March 2015. Photo: Hindustan Times Hyderabad: Existence ...Livemint.com, 1 day ago
The Grocery Manufacturers Association issued the following statement from Pamela G. Bailey, president and CEO, in response to the FDA decision to deny a petition seeking mandatory labeling of genetically modified organisms (GMOs) in food products. ...Packaging Network, 2 days ago GMA Welcomes Release Of Final FSMA Rules Grocery Retail Online.com, 1 week ago
More from: Food Online, Noodls...and 2 other sources
WORCESTER, Mass. , Nov. 17, 2015 /PRNewswire/ --Cogmedix, a wholly owned subsidiary of Coghlin Companies, Inc. and an FDA-compliant medical device engineering and manufacturing services provider, has promoted Scott Cook to Vice President of Quality ...Town Hall, 1 week ago
Amidst growing drug development and manufacturing costs, setting up globalized drug making sites has become more common among pharma companies in the last decade or so, comments Dr Nicola Davies in her monthly exclusive for The Pharma Letter.Pharma Letter, 1 hour ago
18-Nov-2015 Africa and Middle East | Manufacturing | Regulatory Hikma Pharmaceuticals, a Jordan-based multinational pharmaceutical group, has received a letter from the US Food and Drug Administration closing out the warning letter the firm ...Manufacturing Chemist, 1 week ago
Baxalta, a Baxter International spin offformed in July, announced that its state-of-the-art recombinant biologic manufacturing facility in Singapore received U.S. FDA approval to manufacture bulk drug substance for Advate, Baxalta's market leading ...Pharmaceutical Manufacturing Magazine, 1 week ago
Agency Information Collection Activities; Announcement of Office of Management and Budget Approval; Current Good Manufacturing Practice, Hazard...
Agency Information Collection Activities; Announcement of Office of Management and Budget Approval; Current Good Manufacturing Practice, Hazard Analysis, and Risk-Based Preventive Controls for Food for Animals Notice. Citation: "80 FR 70236" ...Pharmacy Choice, 1 week ago
MUMBAI: Dr Reddy's Laboratories tumbled 10% in morning trade with investors dumping the stock as more detailed analysis emerged of warnings received earlier in the month from the US Food and Drug Administration over manufacturing practices. The US ...Economic Times, 8 hours ago
Shares in Dr. Reddy's Laboratories fell as much as 8.5 percent Thursday after the FDA posted a previously disclosed letter warning the company over violations of good manufacturing practices. According to the letter posted on November 24, the agency ...FirstWord Pharma, 4 hours ago US Regulator Gives Dr Reddy's Additional Time to Respond to Warning Letter MyInforms, 5 hours ago Dr. Reddy's Declines in Mumbai After FDA Posts Warning Letter Bloomberg, 12 hours ago Dr Reddy's Laboratories shares fall 8.21 per cent Business Today India, 1 hour ago
More from: , Economic Times...and 5 other sources
on your WebpageAdd Widget >Get your members hooked!